27-hydroxycholesterol has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alfaqih, M; Behrove, MS; Chi, JT; Dambal, S; Driver, LM; Freedland, SJ; Freeman, MR; Galvan, GC; Macias, E; Maravilla, E; Ramirez-Torres, A; Reis-Sobreiro, M; Rotinen, M; Sanders, S; Talisman, TJ; Turkson, J; Yoon, J; You, S | 1 |
| Ghribi, O; Hammer, K; Marwarha, G; Raza, S | 1 |
| He, S; Nelson, ER | 1 |
2 review(s) available for 27-hydroxycholesterol and Prostatic Neoplasms
| Article | Year |
|---|---|
27-hydroxycholesterol: A novel player in molecular carcinogenesis of breast and prostate cancer.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Death; Cell Proliferation; Endoplasmic Reticulum Stress; Female; Humans; Hydroxycholesterols; Male; Prostatic Neoplasms | 2017 |
27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.
Topics: Animals; Atherosclerosis; Breast Neoplasms; Cognitive Dysfunction; Female; Humans; Hydroxycholesterols; Male; Osteoporosis; Prostatic Neoplasms; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2017 |
1 other study(ies) available for 27-hydroxycholesterol and Prostatic Neoplasms
| Article | Year |
|---|---|
27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Cholesterol; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Interleukin-6; Janus Kinase 1; Male; Membrane Microdomains; Mice; Mice, SCID; Prognosis; Prostatic Neoplasms; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |